Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-014327
Filing Date
2026-03-03
Accepted
2026-03-03 20:42:43
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772588561.html 4  
1 FORM 4 wk-form4_1772588561.xml 4 14942
  Complete submission text file 0001628280-26-014327.txt   16639
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 2945 TOWNSGATE ROAD, SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address
Watanabe Todd (Reporting) CIK: 0001801061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 26718402